Abstract
Objectives
To identify MRI features for differentiating type 2 from type 1 intraductal papillary neoplasms of bile duct (IPNB) and assessing malignant potential of IPNB.
Methods
This retrospective study included 60 patients with surgically proven IPNB who had undergone preoperative MRI between January 2007 and December 2020. All surgical specimens were reviewed retrospectively to classify types 1 and 2 IPNBs and assess tumor grade. Significant MRI features for differentiating type 2 (n = 40) from type 1 IPNB (n = 20); and for IPNB with an associated invasive carcinoma (n = 43) from intraepithelial neoplasia (n = 17) were determined using logistic regression analysis.
Results
An associated invasive carcinoma was more frequently found in type 2 than in type 1 IPNB (85.0% [34/40] vs. 45.0% [9/20], p = 0.003). At univariable analysis, MRI features including extrahepatic location, no dilatation of tumor-bearing segment of bile duct, isolated upstream bile duct dilatation, and single lesion were associated with type 2 IPNB (all p ≤ 0.012). At multivariable analysis, significant MRI findings for differentiating type 2 from type 1 IPNB were extrahepatic location and no dilatation of tumor-bearing segment of bile duct (odds ratio [OR], 7.24 and 46.40, respectively). At univariable and multivariable analysis, tumor size ≥ 2.5 cm (OR, 8.45), bile duct wall thickening (OR, 4.82), and irregular polypoid or nodular tumor shape (OR, 6.44) were significant MRI features for differentiating IPNB with an associated invasive carcinoma from IPNB with intraepithelial neoplasia.
Conclusion
MRI with MR cholangiopancreatography may be helpful in differentiating type 2 IPNB from type 1 IPNB and assessing malignant potential of IPNB.
Clinical relevance statement
Preoperative MRI with MR cholangiopancreatography may be helpful in differentiating type 2 intraductal papillary neoplasms of bile duct (IPNB) from type 1 IPNB and assessing malignant potential of IPNB.
Key Points
• In terms of tumor grade, the incidence of invasive carcinoma was significantly higher in type 2 intraductal papillary neoplasm of the bile duct (IPNB) than in type 1 IPNB.
• At MRI, extrahepatic location and no dilatation of tumor-bearing segment are significant features for differentiating type 2 IPNBs from type 1 IPNBs.
• At MRI, large tumor size, bile duct wall thickening, and irregular polypoid or nodular tumor shape are significant features for differentiating IPNB with an associated invasive carcinoma from IPNB with intraepithelial neoplasia.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00330-023-10491-9/MediaObjects/330_2023_10491_Fig1_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00330-023-10491-9/MediaObjects/330_2023_10491_Fig2_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00330-023-10491-9/MediaObjects/330_2023_10491_Fig3_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00330-023-10491-9/MediaObjects/330_2023_10491_Fig4_HTML.png)
Similar content being viewed by others
Abbreviations
- ADC:
-
Apparent diffusion coefficient
- CER:
-
Contrast enhancement ratio
- CI:
-
Confidence interval
- DWI:
-
Diffusion-weighted imaging
- GRE:
-
Gradient echo
- IPMN:
-
Intraductal papillary mucinous neoplasm
- IPNB:
-
Intraductal papillary neoplasm of the bile duct
- MRCP:
-
MR cholangiopancreatography
- OR:
-
Odds ratio
- RFS:
-
Recurrence-free survival
- WHO:
-
World Health Organization
References
Nakanuma Y, Uesaka K, Miyayama S, Yamaguchi H, Ohtsuka M (2017) Intraductal neoplasms of the bile duct. A new challenge to biliary tract tumor pathology. Histol Histopathol 32:1001–1015
Ainechi S, Lee H (2016) Updates on precancerous lesions of the biliary tract: biliary precancerous lesion. Arch Pathol Lab Med 140:1285–1289
Nakanuma Y, Uesaka K, Kakuda Y et al (2020) Intraductal papillary neoplasm of bile duct: updated clinicopathological characteristics and molecular and genetic alterations. J Clin Med 9:3991
Nakanuma Y, Jang KT, Fukushima N et al (2018) A statement by the Japan-Korea expert pathologists for future clinicopathological and molecular analyses toward consensus building of intraductal papillary neoplasm of the bile duct through several opinions at the present stage. J Hepatobiliary Pancreat Sci 25:181–187
Schlitter AM, Born D, Bettstetter M et al (2014) Intraductal papillary neoplasms of the bile duct: stepwise progression to carcinoma involves common molecular pathways. Mod Pathol 27:73–86
Rocha FG, Lee H, Katabi N et al (2012) Intraductal papillary neoplasm of the bile duct: a biliary equivalent to intraductal papillary mucinous neoplasm of the pancreas? Hepatology 56:1352–1360
Kubota K, Nakanuma Y, Kondo F et al (2014) Clinicopathological features and prognosis of mucin-producing bile duct tumor and mucinous cystic tumor of the liver: a multi-institutional study by the Japan Biliary Association. J Hepatobiliary Pancreat Sci 21:176–185
Jung G, Park KM, Lee SS, Yu E, Hong SM, Kim J (2012) Long-term clinical outcome of the surgically resected intraductal papillary neoplasm of the bile duct. J Hepatol 57:787–793
Nakanuma Y, Basturk O, Esposito I, Klimstra DS, Komuta M, Zen Y (2019) Intraductal papillary neoplasm of the bile ducts. WHO Classification of Tumours of the Digestive System 5th edition. edn. IARC, Lyon
Kubota K, Jang JY, Nakanuma Y et al (2020) Clinicopathological characteristics of intraductal papillary neoplasm of the bile duct: a Japan-Korea collaborative study. J Hepatobiliary Pancreat Sci 27:581–597
Joo I, Lee JM, Yoon JH (2018) Imaging diagnosis of intrahepatic and perihilar cholangiocarcinoma: recent advances and challenges. Radiology 288:7–13
Joo I, Lee JM (2013) Imaging bile duct tumors: pathologic concepts, classification, and early tumor detection. Abdom Imaging 38:1334–1350
Yoon HJ, Kim YK, Jang KT et al (2013) Intraductal papillary neoplasm of the bile ducts: description of MRI and added value of diffusion-weighted MRI. Abdom Imaging 38:1082–1090
Ohtsuka M, Shimizu H, Kato A et al (2014) Intraductal papillary neoplasms of the bile duct. Int J Hepatol 2014:459091
Kang MJ, Jang JY, Lee KB, Han IW, Kim SW (2013) Impact of macroscopic morphology, multifocality, and mucin secretion on survival outcome of intraductal papillary neoplasm of the bile duct. J Gastrointest Surg 17:931–938
Park HJ, Kim SY, Kim HJ et al (2018) Intraductal papillary neoplasm of the bile duct: clinical, imaging, and pathologic features. AJR Am J Roentgenol 211:67–75
Lee S, Kim MJ, Kim S, Choi D, Jang KT, Park YN (2019) Intraductal papillary neoplasm of the bile duct: assessment of invasive carcinoma and long-term outcomes using MRI. J Hepatol 70:692–699
Nakanuma Y, Sato Y, Ojima H et al (2014) Clinicopathological characterization of so-called “cholangiocarcinoma with intraductal papillary growth” with respect to “intraductal papillary neoplasm of bile duct (IPNB).” Int J Clin Exp Pathol 7:3112–3122
Takanami K, Yamada T, Tsuda M et al (2011) Intraductal papillary mucininous neoplasm of the bile ducts: multimodality assessment with pathologic correlation. Abdom Imaging 36:447–456
Mc G, Fowler KJ, Roudenko A et al (2021) How to use LI-RADS to report liver CT and MRI observations. Radiographics 41:1352–1367
Viera AJ, Garrett JM (2005) Understanding interobserver agreement: the kappa statistic. Fam Med 37:360–363
Nakanuma Y, Kakuda Y, Uesaka K (2019) Characterization of intraductal papillary neoplasm of the bile duct with respect to the histopathologic similarities to pancreatic intraductal papillary mucinous neoplasm. Gut Liver 13:617–627
Ohtsuka M, Kimura F, Shimizu H et al (2011) Similarities and differences between intraductal papillary tumors of the bile duct with and without macroscopically visible mucin secretion. Am J Surg Pathol 35:512–521
Komori T, Inoue D, Zen Y et al (2019) CT imaging comparison between intraductal papillary neoplasms of the bile duct and papillary cholangiocarcinomas. Eur Radiol 29:3132–3140
Nakanishi Y, Zen Y, Kawakami H et al (2008) Extrahepatic bile duct carcinoma with extensive intraepithelial spread: a clinicopathological study of 21 cases. Mod Pathol 21:807–816
Igami T, Nagino M, Oda K et al (2009) Clinicopathologic study of cholangiocarcinoma with superficial spread. Ann Surg 249:296–302
Yoon JH, Lee JM, Yu MH, Kim EJ, Han JK, Choi BI (2014) High-resolution T1-weighted gradient echo imaging for liver MRI using parallel imaging at high-acceleration factors. Abdom Imaging 39:711–721
Yoon JH, Nickel MD, Peeters JM, Lee JM (2019) Rapid imaging: recent advances in abdominal MRI for reducing acquisition time and its clinical applications. Korean J Radiol 20:1597–1615
Yoon JH, Lee SM, Kang HJ et al (2017) Clinical feasibility of 3-dimensional magnetic resonance cholangiopancreatography using compressed sensing: comparison of image quality and diagnostic performance. Invest Radiol 52:612–619
Banales JM, Marin JJG, Lamarca A et al (2020) Cholangiocarcinoma 2020: the next horizon in mechanisms and management. Nat Rev Gastroenterol Hepatol 17:557–588
Sakai Y, Ohtsuka M, Sugiyama H et al (2021) Current status of diagnosis and therapy for intraductal papillary neoplasm of the bile duct. World J Gastroenterol 27:1569–1577
Lim JH, Yi CA, Lim HK, Lee WJ, Lee SJ, Kim SH (2002) Radiological spectrum of intraductal papillary tumors of the bile ducts. Korean J Radiol 3:57–63
Funding
This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) (No. NRF-2020R1A2C2006031).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Guarantor
The scientific guarantor of this publication is Jeong Min Lee.
Conflict of interest
The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.
Statistics and biometry
No complex statistical methods were necessary for this paper.
Informed consent
This study was approved by the Institutional Review Board of Seoul National University Hospital (IRB No. H-1911–077-1078).
Ethical approval
Institutional Review Board approval was obtained.
Study subjects or cohorts overlap
Not applicable.
Methodology
• retrospective
• observational
• performed at one institution
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Jeon, S.K., Lee, J.M., Yoo, J. et al. Intraductal papillary neoplasm of the bile duct: diagnostic value of MRI features in differentiating pathologic subclassifications—type 1 versus type 2. Eur Radiol 34, 4674–4685 (2024). https://doi.org/10.1007/s00330-023-10491-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00330-023-10491-9